...
首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Comparison between original and generic versions of ceftriaxone sodium preparation for injection: Compatibility with calcium-containing product
【24h】

Comparison between original and generic versions of ceftriaxone sodium preparation for injection: Compatibility with calcium-containing product

机译:头孢曲松钠注射液原始版本和通用版本的比较:与含钙产品的兼容性

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to compare the compatibility of ROCEPHINE? Intravenous, the original manufacturer's ceftriaxone sodium preparation for injection, and seven generic versions thereof, with various calcium chloride injection 2%. The influence of calcium ion concentration, storage time and shaking strength on the appearance and quantity of insoluble microparticles in mixed solutions was examined using a light obscuration particle counter. In all products, the observed number of insoluble microparticles was proportional to the calcium ion concentration, storage time and shaking strength after the addition of calcium chloride solution. In several of the generic products, the number of insoluble microparticles was significantly higher than those of the original product, while in others it was lower. We evaluated the quality of the original and 7 generic preparations, measured the content of impurity and pH of the various ceftriaxone solutions, as impurity content and pH of solution are possible factor affecting compatibility. Three impurities were found in all products. The impurity content of several generic products, as estimated from their peak area on high performance liquid chromatography (HPLC), was significantly lower than that of the original product. pH of solution was difference between products. Although it was difficult that impurity and pH of solution verify critical factor affecting compatibility. The results show that there are differences in the appearance of insoluble microparticles between the original product and seven generic products, when calcium chloride injection 2% solution is added to the product.
机译:这项研究的目的是比较ROCEPHINE的相容性。静脉注射,原始制造商的头孢曲松钠注射液制剂,及其七个通用版本,各种氯化钙注射液浓度为2%。使用光遮蔽粒子计数器检查了钙离子浓度,储存时间和摇动强度对混合溶液中不溶性微粒的外观和数量的影响。在所有产品中,添加氯化钙溶液后,观察到的不溶性微粒数量与钙离子浓度,储存时间和摇动强度成正比。在一些通用产品中,不溶性微粒的数量明显高于原始产品,而在其他产品中则更低。我们评估了原始制剂和7种通用制剂的质量,测量了各种头孢曲松溶液的杂质含量和pH值,因为溶液中的杂质含量和pH值可能是影响相容性的因素。在所有产品中发现了三种杂质。从高效液相色谱(HPLC)的峰面积估算,几种通用产品的杂质含量明显低于原始产品。溶液的pH是产品之间的差异。尽管很难通过杂质和溶液的pH值来确定影响相容性的关键因素。结果表明,当向产品中添加2%氯化钙注射液时,原始产品和七个通用产品之间的不溶性微粒外观存在差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号